Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be
wrong. If given in a few (even single) fractions, but at a high fraction dose, stereotactic body …

Abstract Learning Objectives After completing this course, the reader will be able to: Assess
stereotactic body radiation therapy (SBRT) as an emerging modality in the treatment of …

PURPOSE: To evaluate the outcome of robotic CyberKnife (Accuray, Sunnyvale, CA)–based
stereotactic radiotherapy (CBK-SRT) for isolated recurrent primary, lymph node, or …

Background We investigated whether repeated stereotactic body radiotherapy (SBRT) of
oligometastatic disease is able to defer the initiation of palliative androgen deprivation …

Objective: To evaluate high-precision external beam reirradiation (re-EBRT) for local relapse
of prostate cancer (PCa) after radiotherapy. Methods: This retrospective study included …

Background The purpose of the study was to evaluate the prostate serum antigen (PSA)
response, local control, progression-free survival (PFS), and toxicity of stereotactic body …

Background SBRT is a novel modality in treatment for oligometastatic colorectal cancer. We
aimed to perform a systematic review of results of SBRT in maintaining LC (local control) for …

Introduction Following growing evidence to support the safety, local control (LC) and
potential improvement in overall survival (OS) in patients with oligometastatic non-small cell …

Purpose To evaluate, in prostate cancer (PCa) patients the potential of 11 C-choline PET/CT
as a guide to helical tomotherapy (HTT) of lymph-node (LN) relapses with simultaneous …

Advances in radiotherapy planning and delivery have been used to treat patients with
limited metastatic disease. With these techniques, high rates of treated metastasis control …